> Germany's Schwarz Pharma received a thumb's up from a European medicines panel for its Neupro patch for patients with Parkinson's disease. Report
> Chutes & Ladders: U.S. Genomics has promoted John J. Canepa to CEO. Canepa originally joined U.S. Genomics as chief financial officer. Release
> Researchers say the psoriasis drug Enbrel also appears to work against depression and fatigue that is common among sufferers of the disease. Release
> Inamed's board has approved the acquisition of Allergan. Report
> Chutes & Ladders: Third Wave Technologies has named Kevin T. Conroy president and CEO. Conroy succeeds John J. Puisis, who has resigned. Release
And Finally… Congressional negotiators have rallied behind a bill that would put cold medications under lock and key in a move that may bolster a new push to approve OTC Plan B. Article